NEW YORK, Nov. 7 (GenomeWeb News) - Amersham announced today that Eli Lilly has licensed the rights to Amersham's Aequorea Victoria Green Fluorescent Protein and has secured rights to operate under Biolmage's Redistribution patent portfolio for monitoring intracellular signaling pathways.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.